UNSPSC 85524026: Supplement left brachial vein with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left brachial vein with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05UA4JZ

UNSPSC 85524026 Supplement left brachial vein with synthetic substitute, percutaneous endoscopic approach is a Commodity code that shows no meaningful alignment with state and local procurement activity. The code describes a specific surgical procedure — implantation of a synthetic vascular graft in the left upper extremity using minimally invasive technique — yet the six recent state and local contract opportunities tagged under it procure services that fall outside vascular surgery, including independent medical evaluations for pension disability determinations, Center of Excellence networks for general surgery benefits, occupational medical surveillance, emergency and specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing across multiple ancillary clinical categories. None of these opportunities involve the procurement of implantable devices, vascular grafts, or surgical supplies aligned with the code's nominal scope.

The mismatch between the code's clinical definition and the actual work being solicited suggests either a cataloging error in the source data or a broad misapplication of the commodity code at the issuing-body level. State and local governments do not typically procure individual surgical procedures or implantable medical devices through RFP or RFQ mechanisms; such items flow through group purchasing organizations, hospital supply contracts, or medical device distributors. The opportunities shown here are administrative health services, staffing, and benefit management contracts with no connection to vascular implants. Until opportunities materially aligned with synthetic vascular graft procurement appear in the record, this code does not represent a meaningful pursue target for firms offering medical devices, implant systems, or surgical supplies.